Vanguard Group
AHCO icon

Vanguard Group’s AdaptHealth AHCO Stock Holding History

Vanguard Group’s Portfolio AHCO Stock Details AHCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$117M Buy
11,768,599
+491,106
+4% +$4.69M ﹤0.01% 1811
2025
Q3 		$101M Sell
11,277,493
-576,086
-5% -$5.34M ﹤0.01% 1860
2025
Q2 		$112M Sell
11,853,579
-400,012
-3% -$3.53M ﹤0.01% 1787
2025
Q1 		$133M Sell
12,253,591
-287,083
-2% -$2.89M ﹤0.01% 1664
2024
Q4 		$119M Sell
12,540,674
-14,495
-0.1% -$147K ﹤0.01% 1791
2024
Q3 		$141M Buy
12,555,169
+1,864,057
+17% +$19.8M ﹤0.01% 1721
2024
Q2 		$107M Buy
10,691,112
+673,390
+7% +$6.84M ﹤0.01% 1798
2024
Q1 		$115M Buy
10,017,722
+818,241
+9% +$6.95M ﹤0.01% 1791
2023
Q4 		$67.1M Buy
9,199,481
+542,928
+6% +$4.28M ﹤0.01% 2064
2023
Q3 		$78.8M Buy
8,656,553
+355,005
+4% +$4.26M ﹤0.01% 1927
2023
Q2 		$101M Buy
8,301,548
+28,340
+0.3% +$316K ﹤0.01% 1844
2023
Q1 		$103M Buy
8,273,208
+61,391
+0.7% +$1.13M ﹤0.01% 1815
2022
Q4 		$158M Buy
8,211,817
+416,567
+5% +$8.81M ﹤0.01% 1565
2022
Q3 		$146M Buy
7,795,250
+1,053,942
+16% +$21.7M ﹤0.01% 1575
2022
Q2 		$122M Sell
6,741,308
-446,739
-6% -$7.25M ﹤0.01% 1699
2022
Q1 		$115M Buy
7,188,047
+28,749
+0.4% +$517K ﹤0.01% 1862
2021
Q4 		$175M Buy
7,159,298
+163,970
+2% +$3.85M ﹤0.01% 1689
2021
Q3 		$163M Buy
6,995,328
+106,276
+2% +$2.57M ﹤0.01% 1720
2021
Q2 		$189M Sell
6,889,052
-428,996
-6% -$12.2M ﹤0.01% 1662
2021
Q1 		$269M Buy
7,318,048
+4,438,009
+154% +$157M 0.01% 1406
2020
Q4 		$108M Buy
2,880,039
+1,373,545
+91% +$42.5M ﹤0.01% 1789
2020
Q3 		$32.9M Buy
1,506,494
+1,209,441
+407% +$25.4M ﹤0.01% 2231
2020
Q2 		$4.78M Buy
297,053
+211,173
+246% +$3.53M ﹤0.01% 3116
2020
Q1 		$1.37M Buy
85,880
+50,515
+143% +$714K ﹤0.01% 3411
2019
Q4 		$388K Buy
+35,365
New +$351K ﹤0.01% 3843

Other funds holding AHCO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OCA
OEP Capital Advisors New York $194M AUM 9.78% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SC
SkyKnight Capital San Francisco, California $107M AUM 9.69% 1-Year Est. Return
RP
Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return

Vanguard Group's AHCO Position: Q4 2025 in Review

Vanguard Group increased its AdaptHealth (AHCO) stake by 4.4% in Q4 2025, buying an estimated $4.69M and bringing the position to 11,768,599 shares worth $117M. The position accounts for ﹤0.01% of the portfolio, ranked #1811.

Vanguard Group first reported a position in AHCO in Q4 2019 and has held it in 25 quarters since. The position peaked at $269M in Q1 2021. 231 funds tracked by Wall St. Rank hold AHCO as of Q4 2025.

  • Vanguard Group held 11,768,599 shares of AdaptHealth worth $117M as of Q4 2025.
  • Vanguard Group bought 491,106 AdaptHealth shares in Q4 2025, an estimated $4.69M.
  • AdaptHealth made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #1811 holding.
  • Vanguard Group first reported a position in AdaptHealth in Q4 2019 and has held it in 25 quarters since.
  • Vanguard Group's AdaptHealth position peaked at $269M in Q1 2021.
  • 231 funds tracked by Wall St. Rank held AdaptHealth as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.